Lipid Nanoparticles for Nasal/Intranasal Drug Delivery
The DOI matches its Crossref record.
Abstract
Studies on the development of drug delivery systems have increased because these systems have particular characteristics that allow them to improve therapeutics. Among these, lipid nanoparticles (solid lipid nanoparticles, SLNs; and nanostructured lipid carriers, NLCs) have demonstrated suitability for drug targeting. The nasal administration of drug-loaded lipid nanoparticles showed effectiveness in treating central nervous system (CNS) disorders, particularly neurodegenerative diseases, because the nasal route (also called intranasal route) allows direct nose-to-brain drug delivery by means of lipid nanoparticles. Nonetheless, the feasibility of this application remains an open field for researchers. Drawbacks must be overcome before reaching the clinic (e.g., drug absorption at subtherapeutic levels, rapid mucociliary clearance). The intranasal administration of drugs for systemic absorption is effective for treating other conditions, such as cardiovascular diseases, infections, severe pain, and menopausal syndrome. In the near future, it is expected that patients will benefit from the advantages of lipid nanoparticle-based formulations, via the nasal/intranasal route, which bypasses the blood-brain barrier (BBB), avoiding first-pass metabolism and gastrointestinal degradation. This review discusses the use of SLNs and NLCs for nasal drug administration. A brief description of the nasal route and the features of SLNs and NLCs is initially provided.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Garcês, A., Amaral, M. H., Sousa Lobo, J. M., & Silva, A. C. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.11.023 · Cited by 396
Self-citationCosta, C. P., Moreira, J. N., Sousa Lobo, J. M., & Silva, A. C. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.02.012 · Cited by 303
Self-citationOn a highway to the brain: A review on nose-to-brain drug delivery using nanoparticles
Formica, M. L., Real, D. A., Picchio, M. L., Catlin, E., Donnelly, R. F., & Paredes, A. J. (2022) · Applied Materials Today · doi:10.1016/j.apmt.2022.101631 · Cited by 282
Xu, J., Chen, Z., Yu, F., Liu, H., Ma, C., Xie, D., Hu, X., Leak, R. K., Chou, S. H. Y., Stetler, R. A., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2018497117 · Cited by 180
Huang, G., Xie, J., Shuai, S., Wei, S., Chen, Y., Guan, Z., Zheng, Q., Yue, P., & Wang, C. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.120182 · Cited by 60
Metadata
- Authors
- Cunha, S., Amaral, M. H., Lobo, J. M. S., & Silva, A. C.
- Venue
- Critical Reviews™ in Therapeutic Drug Carrier Systems
- Publisher
- Begell House
- Published
- 2017
- Volume
- 34
- Issue
- 3
- Pages
- 257-282
- ISSN
- 0743-4863 (ISSN-L)
- OpenAlex
- W2604218485
- Cited by
- 138
- References
- 0
- FWCI
- 3.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lipid Nanoparticles for Nasal/Intranasal Drug Delivery. https://app.cochat.ai/papers/10.1615/critrevtherdrugcarriersyst.2017018693
- The paper
- Cunha, S., Amaral, M. H., Lobo, J. M. S., & Silva, A. C. (2017). Lipid Nanoparticles for Nasal/Intranasal Drug Delivery. Critical Reviews™ in Therapeutic Drug Carrier Systems. https://doi.org/10.1615/critrevtherdrugcarriersyst.2017018693
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.